Limor Selinger

422 total citations
15 papers, 203 citations indexed

About

Limor Selinger is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Limor Selinger has authored 15 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Genetics and 6 papers in Epidemiology. Recurrent topics in Limor Selinger's work include Inflammatory Bowel Disease (9 papers), Eosinophilic Esophagitis (4 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (4 papers). Limor Selinger is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Eosinophilic Esophagitis (4 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (4 papers). Limor Selinger collaborates with scholars based in Israel, United States and Italy. Limor Selinger's co-authors include Shomron Ben‐Horin, Uri Kopylov, Adi Lahat, Doron Yablecovitch, Sandra Neuman, Rami Eliakim, Bella Ungar, Nina Levhar, Henit Yanai and Eyal Klang and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Journal of Crohn s and Colitis.

In The Last Decade

Limor Selinger

14 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Limor Selinger Israel 7 122 111 88 60 33 15 203
Teppei Omori Japan 10 102 0.8× 106 1.0× 98 1.1× 39 0.7× 42 1.3× 37 213
Tomomi Yukawa Japan 11 136 1.1× 70 0.6× 35 0.4× 101 1.7× 53 1.6× 18 232
Haim Leibovitzh Israel 8 60 0.5× 123 1.1× 47 0.5× 56 0.9× 28 0.8× 27 209
Marco Astegiano Italy 6 150 1.2× 118 1.1× 33 0.4× 124 2.1× 75 2.3× 10 246
Laura Cantoro Italy 8 113 0.9× 76 0.7× 26 0.3× 88 1.5× 12 0.4× 10 178
C. Subtil France 7 114 0.9× 130 1.2× 37 0.4× 77 1.3× 92 2.8× 18 258
Joo Young Jang South Korea 7 83 0.7× 104 0.9× 13 0.1× 55 0.9× 22 0.7× 14 192
Sandra El‐Hachem United States 8 204 1.7× 90 0.8× 15 0.2× 177 3.0× 16 0.5× 19 270
A. J.P. van Tilburg Netherlands 5 139 1.1× 171 1.5× 41 0.5× 84 1.4× 28 0.8× 7 249
Rutger Quispel Netherlands 6 60 0.5× 80 0.7× 33 0.4× 71 1.2× 26 0.8× 20 171

Countries citing papers authored by Limor Selinger

Since Specialization
Citations

This map shows the geographic impact of Limor Selinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limor Selinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limor Selinger more than expected).

Fields of papers citing papers by Limor Selinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limor Selinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limor Selinger. The network helps show where Limor Selinger may publish in the future.

Co-authorship network of co-authors of Limor Selinger

This figure shows the co-authorship network connecting the top 25 collaborators of Limor Selinger. A scholar is included among the top collaborators of Limor Selinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limor Selinger. Limor Selinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lahat, Adi, Bella Ungar, Doron Yablecovitch, et al.. (2025). Capsule Endoscopy–Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn’s Disease: A Randomized Controlled Trial. Gastroenterology. 169(1). 85–93.e3. 4 indexed citations
2.
Yablecovitch, Doron, Moshe Nadler, Orit Picard, et al.. (2024). Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma. Cancer Medicine. 13(17). e70144–e70144. 2 indexed citations
3.
Yablecovitch, Doron, Adi Lahat, Limor Selinger, et al.. (2023). Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease. Therapeutic Advances in Gastroenterology. 16. 1108371563–1108371563. 2 indexed citations
4.
Yavzori, Miri, Ella Fudim, Orit Picard, et al.. (2023). Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study. Journal of Crohn s and Colitis. 18(3). 341–348. 1 indexed citations
5.
Kopylov, Uri, Bella Ungar, Limor Selinger, et al.. (2022). Patency Capsule: A Novel Independent Predictor for Long-Term Outcomes Among Patients With Quiescent Crohn's Disease. The American Journal of Gastroenterology. 118(6). 1019–1027. 12 indexed citations
6.
Yablecovitch, Doron, Shomron Ben‐Horin, Orit Picard, et al.. (2022). Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma. Clinical and Translational Gastroenterology. 13(5). e00473–e00473. 11 indexed citations
7.
Ziv‐Baran, Tomer, Ella Fudim, Miri Yavzori, et al.. (2022). Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening. Therapeutic Advances in Gastroenterology. 15. 1098266371–1098266371. 1 indexed citations
8.
Eliakim, Rami, Doron Yablecovitch, Adi Lahat, et al.. (2020). A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease. United European Gastroenterology Journal. 8(5). 544–551. 39 indexed citations
9.
Ben‐Horin, Shomron, Adi Lahat, Marianne Michal Amitai, et al.. (2019). Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study. ˜The œLancet. Gastroenterology & hepatology. 4(7). 519–528. 66 indexed citations
10.
Ungar, Bella, Limor Selinger, Ahmad Albshesh, et al.. (2019). Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease. United European Gastroenterology Journal. 8(2). 167–174. 13 indexed citations
11.
Yablecovitch, Doron, Uri Kopylov, Adi Lahat, et al.. (2019). Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysis. Therapeutic Advances in Gastroenterology. 12. 3973070454–3973070454. 20 indexed citations
13.
Yablecovitch, Doron, Uri Kopylov, Adi Lahat, et al.. (2018). Su1178 - Serum MMP-9 - A Novel Biomarker for Prediction of Clinical Relapse in Patients with Quiescent small Bowel Crohn's Disease. Gastroenterology. 154(6). S–495. 1 indexed citations
14.
Lahat, Adi, Ariella Bar‐Gil Shitrit, Timna Naftali, et al.. (2017). Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 12(1). 120–123. 27 indexed citations
15.
Scope, Alon, Limor Selinger, Margaret Oliviero, et al.. (2016). Precise Longitudinal Tracking of Microscopic Structures in Melanocytic Nevi Using Reflectance Confocal Microscopy. JAMA Dermatology. 152(3). 299–299. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026